By Night
PhUSE 2017 SDE - Chilly-Mazarin, France - Complexe Sportif Jesse Owens - Chilly-Mazarin
Le
De 09h00 à 17h00
Complexe Sportif Jesse Owens - Chilly-Mazarin
Place Du 8 Mai 1945
91380
Chilly-Mazarin
Theme: Clinical Trials Analysis on Real-World Evidence – Where is the frontier?
Description:
In an application of the overall PhUSE theme this year, "Digital Innovation in Healthcare", this topic will provide the opportunity to share experiences on the new concepts, trends and solutions related to interoperability and technology used to support both Randomized Clinical Trials (RCT) and Real World Data (RWD).
Randomized Clinical Trials (RCT) remain the trusted standard for assessing pharmaceutical drug and medical device safety and efficacy. RCTs use a carefully planned experimental framework to compare a proposed treatment against a control, investigate and analyze the effect of each treatment to determine if the defined outcomes are achieved. RCTs are structured and controlled, such as patient inclusion criteria and the documented focus or purpose of the trial, to achieve the objectives of the trial.
Digital Innovation in Healthcare, focusing on Real World Data, collects and analyses more and more sources of data (social media, smart phones, activity trackers, electronic health records, etc). The importance of this RWD to support advances in healthcare are becoming more evident. When important health information about patients is available to fill the knowledge gap between clinical trials and actual clinical practices, researchers have a better understanding how treatments work when applied in practice. The hope is that properly analyzed RWD can provide key insights that will help drive down medical costs, as well as improve both product safety and effectiveness. Compared to the RCTs, RWD multiple data sources allow for learning beyond the focus of the study.
RWE studies are useful complements to RCTs, as they reflect the day-to-day utility of drugs, devices and other products, providing a more comprehensive view of patient response to medications, a better understanding of disease patterns, additional safety data, as well as data for economic analyses.
Location:
Sanofi Offices
Chilly-Mazarin
Description:
In an application of the overall PhUSE theme this year, "Digital Innovation in Healthcare", this topic will provide the opportunity to share experiences on the new concepts, trends and solutions related to interoperability and technology used to support both Randomized Clinical Trials (RCT) and Real World Data (RWD).
Randomized Clinical Trials (RCT) remain the trusted standard for assessing pharmaceutical drug and medical device safety and efficacy. RCTs use a carefully planned experimental framework to compare a proposed treatment against a control, investigate and analyze the effect of each treatment to determine if the defined outcomes are achieved. RCTs are structured and controlled, such as patient inclusion criteria and the documented focus or purpose of the trial, to achieve the objectives of the trial.
Digital Innovation in Healthcare, focusing on Real World Data, collects and analyses more and more sources of data (social media, smart phones, activity trackers, electronic health records, etc). The importance of this RWD to support advances in healthcare are becoming more evident. When important health information about patients is available to fill the knowledge gap between clinical trials and actual clinical practices, researchers have a better understanding how treatments work when applied in practice. The hope is that properly analyzed RWD can provide key insights that will help drive down medical costs, as well as improve both product safety and effectiveness. Compared to the RCTs, RWD multiple data sources allow for learning beyond the focus of the study.
RWE studies are useful complements to RCTs, as they reflect the day-to-day utility of drugs, devices and other products, providing a more comprehensive view of patient response to medications, a better understanding of disease patterns, additional safety data, as well as data for economic analyses.
Location:
Sanofi Offices
Chilly-Mazarin
0 Commentaire Soyez le premier à réagir